#POLB Poolbeg Pharma PLC – Results for the year ended 31 December 2022 March 30, 2023 – Posted in: Poolbeg Pharma (POLB)

London, UK 30 March 2023 – Poolbeg Pharma Plc (AIM: POLB, OTCQB: POLBF “Poolbeg” or the “Company”) a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, is pleased to announce its audited results for the year ended 31 December 2022.   Financial & Corporate Highlights –       Well capitalised with a cash balance of £16.2m at year end –       Poolbeg-led consortium awarded €2.3m in non-dilutive funding to progress its…

Continue reading